pSivida Corp. (NASDAQ:PSDV) shot up 3.8% on Monday . The stock traded as high as $4.15 and last traded at $4.08, with a volume of 203,453 shares. The stock had previously closed at $3.93.

Separately, FBR & Co reiterated a “buy” rating and issued a $7.00 price target (up from $6.00) on shares of pSivida Corp. in a report on Thursday, May 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $7.00.

The stock’s 50-day moving average price is $3.50 and its 200 day moving average price is $3.13. The company’s market cap is $140.45 million.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.